Neuland Laboratories has officially launched the first module of its commercial peptide manufacturing facility in Hyderabad, ...

Shilpa Biologicals Private Limited has entered into an exclusive strategic licensing and commercialization agreement with ...

The approved variation enables Upperton to commence GMP manufacture of sterile investigational medicinal products from the purpose-built facility, expanding the company’s integrated development and ...

Decisions around trial design, regulatory strategy, and manufacturing planning ultimately determine whether a therapy reaches patients.

This week on "The Friday Brief," companies put down roots on both sides of the Atlantic, expanding their capabilities in a number of areas.